ReviewJournal of hematology & oncology2016

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.

Weijie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.